Researchers in the UK have shown that guanfacine could help to combat leftward spatial exploration deficit in patients with visual neglect due to right-hemisphere stroke. The noradrenergic ...

Non-stimulant ADHD medications, such as atomoxetine and guanfacine, provide effective alternatives to stimulants, addressing ...

The Dementia Trials Accelerator (DTA) – which will be spearheaded by the UK Dementia Research Institute (UK DRI) and Health ...

Intuniv (guanfacine hydrochloride prolonged release tablets) is licensed for children and adolescents of 6 to 17 years old for whom stimulants are not suitable, not tolerated or have been shown to ...

After the girl’s symptoms were loaded into Translator, the tool suggested guanfacine, a drug commonly used to control high blood pressure, as a treatment option. When the girl had been on the ...

Onyda XR can be used in people 6 years of age and older. It is a liquid taken by mouth once daily at bedtime. Intuniv ...

The World Anti-Doping Agency (WADA) has announced the 2025 List of Prohibited Substances and Methods, including the Summary ...

For users of guanfacine it is advised not to stop suddenly, however, it is “usually safe” to stop medications such as methylphenidate, lisdexamfetamine and atomoxetine without needing to ...

The International Tennis Integrity Agency (ITIA) has reacted this week to the Prohibited List published in September by the ...

Intuniv (guanfacine) is a non-stimulant ADHD medication, typically prescribed to children, but also used in adults for managing hyperactivity and impulsivity. Unlike Adderall, Intuniv works by ...

In this case, doctors might try a non-stimulant medication. Non-stimulants: The main second-line non-stimulant treatments are atomoxetine and guanfacine which increase the amount of a chemical in the ...

Adults with attention-deficit/hyperactivity disorder (ADHD) are more frequently presenting for diagnosis and treatment. Medication is considered to be appropriate ...